0
0

Curbing China’s Vaccine Diplomacy Act

12/31/2022, 5:07 AM

Summary of Bill HR 4362

Bill 117 HR 4362, also known as the Curbing China's Vaccine Diplomacy Act, is a piece of legislation introduced in the US Congress with the aim of addressing China's influence in the global vaccine market. The bill seeks to counter China's efforts to use vaccine diplomacy as a tool for expanding its geopolitical influence.

The main provisions of the bill include increasing transparency and accountability in the distribution of vaccines by requiring the US government to report on China's vaccine diplomacy efforts. It also calls for the establishment of a task force to monitor and assess China's vaccine diplomacy activities and their impact on global health security.

Additionally, the bill aims to strengthen US leadership in global health by promoting the development and distribution of safe and effective vaccines. It calls for increased funding for international vaccine initiatives and partnerships to ensure that the US remains a key player in the global vaccine market. Overall, the Curbing China's Vaccine Diplomacy Act is a response to China's growing influence in the global vaccine market and seeks to protect US interests and promote global health security.

Congressional Summary of HR 4362

Curbing China's Vaccine Diplomacy Act

This bill requires the Department of State, in carrying out the international distribution of COVID-19 vaccine doses, to prioritize distribution to and ensure that at least 25% of such doses are reserved for Taiwan and certain Latin American allies.

The State Department may not make such distribution until the Administration determines that all Americans have been afforded ample opportunity to be vaccinated against COVID-19. Further, the State Department must ensure that at least 25% of COVID-19 vaccine doses intended for international distribution are reserved for and distributed to Taiwan and Latin American allies, and it may not distribute any doses internationally to any recipient or country until Taiwan and Latin American allies receive their first shipment of such doses.

Current Status of Bill HR 4362

Bill HR 4362 is currently in the status of Bill Introduced since July 6, 2021. Bill HR 4362 was introduced during Congress 117 and was introduced to the House on July 6, 2021.  Bill HR 4362's most recent activity was Referred to the Subcommittee on Asia, the Pacific, Central Asia and Nonproliferation. as of August 4, 2021

Bipartisan Support of Bill HR 4362

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
6
Democrat Cosponsors
0
Republican Cosponsors
6
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 4362

Primary Policy Focus

International Affairs

Potential Impact Areas

- Asia
- Cardiovascular and respiratory health
- China
- Congressional oversight
- Diplomacy, foreign officials, Americans abroad
- Emergency medical services and trauma care
- Foreign aid and international relief
- Health care coverage and access
- Human rights
- Immunology and vaccination
- Infectious and parasitic diseases
- Latin America
- Taiwan

Alternate Title(s) of Bill HR 4362

To prioritize the international distribution of COVID-19 vaccine doses, and for other purposes.
Curbing China’s Vaccine Diplomacy Act
Curbing China’s Vaccine Diplomacy Act

Comments